Hong Kong to surpass Nasdaq as king of biotech listings in ...

文章推薦指數: 80 %
投票人數:10人

The quest builds on Li's listing reforms in April 2018 that opened the door for such companies, including drugs developers to sell shares to the ... TheHKEXhasattractedaslewofChinese-backedbiotechnologylistingsthisyear.Photo:ReutersLinkCopiedPostTheHKEXhasattractedaslewofChi



請為這篇文章評分?